| AC | Anticoagulation |
| ADAMTS13 | A Disintegrin And Metalloproteinase with Thrombospondin Motifs 13 |
| AFP | Alpha-Fetoprotein |
| ALBI | Albumin Bilirubin |
| Ang-2 | Angiopoietin 2 |
| AnxA5/PS | Annexin A5/Phosphatidylserine |
| AtezoBev | Atezolizumab–Bevacizumab treatment |
| AVB | Acute Variceal Bleeding |
| CD61/CD62P | Cluster of Differentiation 61/62P |
| CI | Confidence Interval |
| CPS | Child–Pugh Score |
| CRP | C-Reactive Protein |
| CSC (EpCAM+) | Cancer Stem Cells (Epithelial Cell Adhesion Molecule positive) |
| CSPH | Clinically Significant Portal Hypertension |
| CTP | Child Turcotte Pugh |
| CXCL | C-X-C Motif Chemokine |
| DOAC | Direct Oral Anticoagulant |
| DVT | Deep Vein Thrombosis |
| ECOG PS | Eastern Cooperative Oncology Group Performance Status |
| EPCR | Endothelial Protein C Receptor |
| ET-1 | Endothelin 1 |
| EVs/MVs | Extracellular Vesicles/Microvesicles |
| HCC | Hepatocellular Carcinoma |
| HMGB1 | High-Mobility Group Box 1 |
| HR | Hazard Ratio |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| IL-6 | Interleukin 6 |
| Lenv | Lenvatinib |
| LMWH | Low-Molecular-Weight Heparin |
| lncRNA | Long Non-Coding RNA |
| LPS | Laparoscopic Surgery |
| LRT | Locoregional Therapy |
| MCF | Maximum Clot Firmness |
| MA | Maximum Amplitude |
| miR | MicroRNA |
| MP | Microparticles |
| MVI | Macrovascular Invasion |
| MWA | Microwave Ablation |
| NETosis | Neutrophil Extracellular Trap Formation |
| NO | Nitric Oxide |
| OLT | Orthotopic Liver Transplantation |
| OR | Odds Ratio |
| OS | Overall Survival |
| PAI-1 | Plasminogen Activator Inhibitor 1 |
| PAP | Plasmin Antiplasmin Complex |
| PE | Pulmonary Embolism |
| pEV | Platelet-derived Extracellular Vesicle |
| PFS | Progression-Free Survival |
| PGI2 | Prostacyclin (Prostaglandin I2) |
| PLT | Platelet Count |
| p-y | Person Years |
| PVT | Portal Vein Thrombosis |
| ROTEM | Rotational Thromboelastometry |
| ROS | Reactive Oxygen Species |
| SVT | Splanchnic Vein Thrombosis |
| TAFI | Thrombin-Activatable Fibrinolysis Inhibitor |
| TEG-PM | Thromboelastography with Platelet Mapping |
| TF | Tissue Factor |
| TGA | Thrombin Generation Assay |
| TM | Thrombomodulin |
| TMPs | Tumor-derived Microparticles |
| TNF-α | Tumor Necrosis Factor alpha |
| TPO | Thrombopoietin |
| uPA/uPAR | Urokinase-type Plasminogen Activator/uPA Receptor |
| vWF | von Willebrand Factor |
| VKA | Vitamin K Antagonist |
| VEGF/VEGFR | Vascular Endothelial Growth Factor/VEGF Receptor |
| VTE | Venous Thromboembolism |
| YAP | Yes-associated Protein |